JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 48 filers reported holding JANUX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $65,422,042 | +28.0% | 1,561,758 | +15.0% | 0.00% | 0.0% |
Q1 2024 | $51,127,195 | +386.5% | 1,357,960 | +38.6% | 0.00% | – |
Q4 2023 | $10,509,853 | +10.7% | 979,483 | +3.9% | 0.00% | – |
Q3 2023 | $9,498,193 | +5.0% | 942,281 | +23.7% | 0.00% | – |
Q2 2023 | $9,044,820 | -3.3% | 761,990 | -1.4% | 0.00% | – |
Q1 2023 | $9,349,125 | -5.9% | 772,655 | +2.4% | 0.00% | – |
Q4 2022 | $9,938,345 | -3.5% | 754,620 | -0.8% | 0.00% | – |
Q3 2022 | $10,297,000 | +29.8% | 760,474 | +17.1% | 0.00% | – |
Q2 2022 | $7,932,000 | -2.3% | 649,640 | +14.8% | 0.00% | – |
Q1 2022 | $8,116,000 | -22.8% | 565,979 | +6.2% | 0.00% | – |
Q4 2021 | $10,517,000 | -8.3% | 533,071 | +0.5% | 0.00% | – |
Q3 2021 | $11,470,000 | +1486.4% | 530,242 | +1729.9% | 0.00% | – |
Q2 2021 | $723,000 | – | 28,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
Parkwood LLC | 33,750 | $412,000 | 0.07% |
Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |